Literature DB >> 30352679

Prostate Luminal Progenitor Cells in Development and Cancer.

Dingxiao Zhang1, Shuhong Zhao2, Xinyun Li2, Jason S Kirk3, Dean G Tang4.   

Abstract

Prostate cancer (PCa) has a predominantly luminal phenotype. Basal cells were previously identified as a cell of origin for PCa, but increasing evidence implicates luminal cells as a preferred cell of origin for PCa, as well as key drivers of tumor development and progression. Prostate luminal cells are understudied compared with basal cells. In this review, we describe the contribution of prostate luminal progenitor (LP) cells to luminal cell development and their role in prostate development, androgen-mediated regeneration of castrated prostate, and tumorigenesis. We also discuss the potential value of LP transcriptomics to identify new targets and therapies to treat aggressive PCa. Finally, we propose future research directions focusing on molecular mechanisms underlying LP cell biology and heterogeneity in normal and diseased prostate.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer stem cells; castration resistance; luminal progenitors; prostate cancer; prostate stem cells

Mesh:

Year:  2018        PMID: 30352679      PMCID: PMC6212301          DOI: 10.1016/j.trecan.2018.09.003

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  86 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.

Authors:  Markus Germann; Antoinette Wetterwald; Natalia Guzmán-Ramirez; Gabri van der Pluijm; Zoran Culig; Marco G Cecchini; Elizabeth D Williams; George N Thalmann
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

Review 3.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

4.  Luminal cells are favored as the cell of origin for prostate cancer.

Authors:  Zhu A Wang; Roxanne Toivanen; Sarah K Bergren; Pierre Chambon; Michael M Shen
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

5.  In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme.

Authors:  Li Xin; Hisamitsu Ide; Yoon Kim; Purnima Dubey; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

6.  Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.

Authors:  Changyong Guo; Haibo Liu; Bao-Hui Zhang; Radu M Cadaneanu; Aqila M Mayle; Isla P Garraway
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

7.  Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress.

Authors:  S M Hein; S Haricharan; A N Johnston; M J Toneff; J P Reddy; J Dong; W Bu; Y Li
Journal:  Oncogene       Date:  2015-06-22       Impact factor: 9.867

8.  Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status.

Authors:  Naitao Wang; Bai-Jun Dong; Yizhou Quan; Qianqian Chen; Mingliang Chu; Jin Xu; Wei Xue; Yi-Ran Huang; Ru Yang; Wei-Qiang Gao
Journal:  Stem Cell Reports       Date:  2016-05-10       Impact factor: 7.765

9.  Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration.

Authors:  Dingxiao Zhang; Collene Jeter; Shuai Gong; Amanda Tracz; Yue Lu; Jianjun Shen; Dean G Tang
Journal:  Stem Cell Reports       Date:  2017-12-21       Impact factor: 7.765

10.  Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.

Authors:  Dingxiao Zhang; Kevin Lin; Yue Lu; Kiera Rycaj; Yi Zhong; Hsueh-Ping Chao; Tammy Calhoun-Davis; Jianjun Shen; Dean G Tang
Journal:  Stem Cells Transl Med       Date:  2016-09-29       Impact factor: 6.940

View more
  22 in total

Review 1.  Prostate luminal progenitor cells: from mouse to human, from health to disease.

Authors:  Manon Baures; Charles Dariane; Elisavet Tika; Emilia Puig Lombardi; Nicolas Barry Delongchamps; Cedric Blanpain; Jacques-Emmanuel Guidotti; Vincent Goffin
Journal:  Nat Rev Urol       Date:  2022-01-25       Impact factor: 14.432

Review 2.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

Review 3.  Immunotherapy for hepatocellular carcinoma.

Authors:  Mingzhen Zhou; Baorui Liu; Jie Shen
Journal:  Clin Exp Med       Date:  2022-08-24       Impact factor: 5.057

4.  A m6Avalue predictive of prostate cancer stemness, tumor immune landscape and immunotherapy response.

Authors:  Cheng Zou; Qinju He; Yuqing Feng; Mengjie Chen; Dingxiao Zhang
Journal:  NAR Cancer       Date:  2022-03-25

Review 5.  Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis.

Authors:  Sukanya Basu; Yang Dong; Rahul Kumar; Collene Jeter; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

6.  Role of Runx2 in prostate development and stem cell function.

Authors:  Yan Li; Chunxi Ge; Renny T Franceschi
Journal:  Prostate       Date:  2021-01-07       Impact factor: 4.104

Review 7.  LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor.

Authors:  Yibing Ji; Rahul Kumar; Abhiram Gokhale; Hseu-Ping Chao; Kiera Rycaj; Xin Chen; Qiuhui Li; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-01-18       Impact factor: 17.012

8.  TGM4: an immunogenic prostate-restricted antigen.

Authors:  Zoila A Lopez-Bujanda; Aleksandar Obradovic; Thomas R Nirschl; Laura Crowley; Rodney Macedo; Alexandros Papachristodoulou; Timothy O'Donnell; Uri Laserson; Jelani C Zarif; Ran Reshef; Tiezheng Yuan; Mithil K Soni; Emmanuel S Antonarakis; Michael C Haffner; H Benjamin Larman; Michael M Shen; Pawel Muranski; Charles G Drake
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

Review 9.  Aging of the progenitor cells that initiate prostate cancer.

Authors:  Jack Freeland; Preston D Crowell; Jenna M Giafaglione; Paul C Boutros; Andrew S Goldstein
Journal:  Cancer Lett       Date:  2021-05-28       Impact factor: 8.679

10.  Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.

Authors:  Dingxiao Zhang; Qiang Hu; Xiaozhuo Liu; Yibing Ji; Hsueh-Ping Chao; Yan Liu; Amanda Tracz; Jason Kirk; Silvia Buonamici; Ping Zhu; Jianmin Wang; Song Liu; Dean G Tang
Journal:  Nat Commun       Date:  2020-04-29       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.